Treatment regimens include leuprolide acetate 7.5 to 15 mg IM every 4 weeks, 11.25 mg or 30 mg IM every 12 weeks, or 45 mg subcutaneously every 6 months; triptorelin 22.5 mg IM every 6 months; or histrelin implants (changed annually).